Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, San Francisco
With
National Center for Complementary and Integrative Health (NCCIH)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
English, Spanish, or Cantonese speaking
Diagnosed with type 2 diabetes mellitus
Distal lower limb pain present for at least three months
A score of 4 or greater on the 11-point Pain Intensity Numerical Rating Scale (PI-NRS) for the pain of diabetic peripheral neuropathy at least four days a week before randomization
Pain characterized as burning, shooting, or stabbing in nature
Ability to understand study procedures and willingness to comply with them for the entire length of the study
A score of less than 8 on the Semmes-Weinstein monofilament test
Stable use of pain control medications for PDN in the one month prior to screening (e.g. no change in prescription) or no use of pain control medications for PDN within the past one month
You may not be if
Substance abuse (as assessed by the Simple Screening Instrument for Substance Abuse)
Unstable medical condition (e.g. severe pulmonary disease, myocardial infarction, severe depressive symptoms)
Electrical therapy (e.g. TENS unit) or patch treatment (e.g. lidocaine or capsaicin) for PDN used within the past two weeks
Acupuncture, moxibustion, cupping or herbal medicine for PDN used within the past two weeks
Pregnancy, planning a pregnancy or breast-feeding
Inability or unwillingness to comply with this study protocol, assessed prior to randomization
Clareo Health | Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN)
